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j Abstract Background With the
exception of studies on folic acid,
little evidence is available con-
cerning other nutrients in the
pathogenesis of congenital heart
defects (CHDs). Fatty acids play a
central role in embryonic devel-
opment, and the B-vitamins
riboflavin and nicotinamide are
co-enzymes in lipid metabolism.
Aim of the study To investigate
associations between the maternal
dietary intake of fats, riboflavin
and nicotinamide, and CHD risk
in the offspring. Methods A case-
control family study was con-
ducted in 276 mothers of a child
with a CHD comprising of 190
outflow tract defects (OTD) and
86 non-outflow tract defects (non-
OTD) and 324 control mothers of
a non-malformed child. Mothers
filled out general and food fre-
quency questionnaires at
16 months after the index-preg-
nancy, as a proxy of the habitual
food intake in the preconception
period. Nutrient intakes (medians)
were compared between cases and
controls by Mann–Whitney U test.
Odds ratios (OR) for the associ-
ation between CHDs and nutrient
intakes were estimated in a
logistic regression model. Results
Case mothers, in particular
mothers of a child with OTD, had
higher dietary intakes of satu-
rated fat, 30.9 vs. 29.8 g/d;
P < 0.05. Dietary intakes of ribo-
flavin and nicotinamide were
lower in mothers of a child with
an OTD than in controls (1.32 vs.
1.41 mg/d; P < 0.05 and 14.6 vs.
15.1 mg/d; P < 0.05, respectively).
Energy, unsaturated fat, choles-
terol and folate intakes were
comparable between the groups.
Low dietary intakes of both ribo-
flavin (<1.20 mg/d) and nicotin-
amide (<13.5 mg/d) increased
more than two-fold the risk of a
child with an OTD, especially in
mothers who did not use vitamin
supplements in the periconcep-
tional period (OR 2.4, 95%CI 1.4–
4.0). Increasing intakes of nico-
tinamide (OR 0.8, 95%CI 0.7–
1.001, per unit standard deviation
increase) decreased CHD risk
independent of dietary folate
intake. Conclusions A maternal
diet high in saturated fats and low
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in riboflavin and nicotinamide
seems to contribute to CHD risk,
in particular OTDs.
j Key words congenital heart
anomaly – saturated fat – B-vita-
mins – risk factors – prevention
Introduction
Cardiovascular malformations affect about six to
eight infants per 1,000 live births per year and are a
leading cause of infant deaths due to congenital
anomalies [2, 14]. Despite the increasing number of
studies focusing on the aetiology of congenital heart
defects (CHDs), currently a cause can be identified
only in 15% of the cases. Complex interactions be-
tween genetic and lifestyle factors have been sug-
gested in which maternal nutrition plays a significant
role in the majority of cases [2]. Best known is the
preventive effect of periconceptional use of folic acid
containing multivitamin supplements on CHD risk
[3]. Shaw et al. [30] showed that maternal use of these
vitamins during the sensitive period of heart devel-
opment reduced the risk of conotruncal heart defects
in particular. Furthermore, our group recently dem-
onstrated that a low dietary intake of vitamin B12 is
an independent risk factor for CHDs [34]. The B-
vitamins folate and vitamin B12 are involved in the
remethylation of homocysteine into methionine.
Insufficient folate supply impairs the methylation of
DNA, lipids and proteins. Furthermore, a compro-
mised folate and/or vitamin B12 status also results in
a mild hyperhomocysteinemia.
Our group and others showed that maternal hype-
rhomocysteinemia increases three- to ten-fold the risk
of a child with CHD [13, 32]. Maternal diabetes has
been associated with CHDs [24] and a clear link is
shown between glycemic control during organogene-
sis and congenital malformations [26]. A number of
studies have demonstrated a positive association
between maternal obesity and CHDs as well [36, 38],
although others reported contradictory results. There
is no doubt that obesity is a phenotype of unhealthy
lifestyle factors such as an excessive consumption of
energy-dense foods. Thus, we became interested in
other nutrients not previously studied that may be
associated with CHDs, i.e., dietary fats and related B-
vitamins. During early embryogenesis, fatty acids play
a crucial role in membrane lipids and act as ligands for
receptors and transcription factors that regulate gene
expression [15]. Oxidation of fatty acids is dependent
on adequate concentrations of the B-vitamins ribo-
flavin and nicotinamide. Besides its role in fat
metabolism, riboflavin acts as a cofactor in the folate
pathway [25, 27]. Nicotinamide is involved in both the
synthesis and oxidation of fatty acids and also plays a
role in the metabolism of certain drugs and toxicants
[18]. Of interest is that the strong maternal use of the
western dietary pattern, e.g., high saturated fats and
low B-vitamins including riboflavin, has been associ-
ated with an almost two-fold increased risk of orofa-
cial clefts [35]. Furthermore, low dietary intakes of
riboflavin and nicotinamide have been associated with
an increased risk of orofacial clefts [29] and spina
bifida [11], respectively. Neural tube defects and oro-
facial clefts share many similarities in the pathogenesis
of CHDs as these birth defects originate from distur-
bances in neural crest cell behaviour by for example
hyperhomocysteinemia and low folate [1, 4, 28].
Therefore, it is conceivable that nutritional factors
implicated in the pathogenesis of neural tube defects
and orofacial clefts also apply to CHDs.
Currently, research on dietary intake of fatty acids,
related B-vitamins other than folate and vitamin B12,
and CHD risk is lacking. Therefore, we aimed to
investigate whether the maternal dietary intakes of
fatty acids and B-vitamins riboflavin and nicotin-
amide differ between mothers of a child with a CHD
and control mothers. This may provide new insights
into the optimal balance and quality of the diet in
women during the reproductive period.
Subjects and methods
j Study population
The HAVEN study, a Dutch acronym for the study of
heart anomalies and the role of genetic and nutritional
factors, is a case-control family study designed to
investigate determinants in the pathogenesis and pre-
vention of CHDs. From June 2003 onwards, the HA-
VEN Study was carried out at the Department of
Obstetrics and Gynaecology of Erasmus MC in Rot-
terdam, The Netherlands. The study design was pre-
viously described in detail [32, 34]. In summary,
children with a CHD were diagnosed in the Sophia
Children’s Hospital/Erasmus MC in Rotterdam, Leiden
University Medical Centre in Leiden, VU University
Medical Centre and Emma Children’s hospital/AMC in
Amsterdam and were recruited with both parents in
358 European Journal of Nutrition (2008) Vol. 47, Number 7
 Steinkopff Verlag 2008
collaboration with two paediatric cardiologists trained
in the same hospital. Medical charts were thoroughly
screened by the child health centre physicians and any
control infant with a congenital anomaly was excluded.
All diagnoses were confirmed by ultrasound and/or
cardiac catheterisation and/or surgery. The CHD
phenotypes were categorized into outflow tract defects
(OTDs), comprising of tetralogy of Fallot (n = 38),
atrioventricular septal defects (n = 27), perimembra-
nous ventricular septal defect (n = 77), aortic valve
stenosis (n = 6), pulmonary valve stenosis (n = 42),
and non-outflow tract defects (non-OTDs) including
coarctation of the aorta (n = 27), transposition of the
great vessels (n = 34), hypoplastic left heart syndrome
(n = 13) and miscellaneous (n = 12). Case and control
children were all singletons. Control children were
enrolled in collaboration with the public child health
care centres in the surroundings of Rotterdam and
were unaffected by any major birth defect. All parents
were Dutch speaking. Maternal pre-existing diabetes
was present in two case mothers and four controls.
Between October 2003 and December 2006, we col-
lected questionnaire data on 351 case mothers and 406
control mothers. Pregnant (cases n = 38, controls
n = 32) or lactating (cases n = 15, controls n = 16)
mothers were excluded. We also excluded mothers
who reported an altered diet compared with the peri-
conception period, e.g. slimming or vegetarian diet
(cases n = 22, controls n = 34). This resulted in the
final evaluation of 276 case mothers and 324 control
mothers. The study protocol was reviewed and ap-
proved by the Central Committee of Research in Hu-
man and the Medical Ethics Committees of the
participating hospitals. A written informed consent
was obtained from every parent.
j Data collection
We collected the dietary intake data at 16 months
after the index-pregnancy. At that time, the diagnosis
of the CHD phenotypes had been confirmed. Dietary
intake was assessed using a modified version of the
semiquantitative food frequency questionnaire (FFQ)
of Feunekes et al. [8] covering the previous 4 weeks.
This for fats validated FFQ has been updated twice
based on data of Dutch national food consumption
surveys in 1992 and 1998 and was also specifically
validated for B vitamin intakes [21, 22, 33]. The FFQ
consisted of 195 items, structured according to a meal
pattern. Questions about preparation methods, por-
tion sizes and additions were included. We used the
2001 electronic version of the Dutch food composi-
tion table to calculate average daily intake of nutrients
[23]. Further details on the FFQ are described else-
where [8, 33].
Nutritional habits are in general rather constant,
with the exception of periods of dieting and increased
needs during pregnancy and lactation [5, 7, 39].
During the first critical pregnancy weeks, materno-
fetal nutrient transfer is largely determined by the
maternal dietary intake of the previous preconception
weeks. Our assumption is that the nutrient data from
the FFQ filled out 24 months after conception reflect
the maternal nutritional status in the preconception
period. Moreover, it resembles the same season of the
year. The value of this approach has been demon-
strated by studies before [19, 34]. The FFQs were filled
out at home and verified by the researcher using a
standardized checklist during the hospital visit or
occasionally during a telephone interview. During the
hospital visit at the Erasmus MC, standardized
anthropometric measurements of the mothers were
performed. Weight (weighing scale, SECA, Hamburg,
Germany) was measured with 0.5 kg accuracy and
height (anthropometric rod, SECA, Hamburg, Ger-
many) up to 0.1 cm accuracy. Body mass index was
defined as weight divided by height squared.
All mothers completed a questionnaire concerning
lifestyle behaviours and demographic data at
16 months after the index-pregnancy and at the
periconception period, defined as four weeks prior to
conception until 8 weeks after conception. Extracted
data included maternal age, time interval after the
index-pregnancy, pre-existing diabetes, educational
level, ethnicity and use of alcohol, cigarettes and
vitamin supplements. Periconception vitamin sup-
plement use was defined as daily intake in the entire
periconception period. Data on vitamin supplements
included information on the contents (folic acid only
or multivitamin supplement) and frequency of intake.
Mothers were considered to use alcohol or cigarettes
when any consumption in the questioned periods was
reported. Mothers were classified by educational level
based on definitions used by Statistics Netherlands
[31]. Primary/lower vocational/intermediate second-
ary level of education was defined as low, intermedi-
ate vocational/higher secondary as intermediate, and
higher vocational/university level as high education.
Ethnicity was categorized as Dutch natives (both
parents are of European origin and born in the
Netherlands), European others (one of the parents is
born in a European country or is of European origin
and living in the USA, Australia or Indonesia), or
non-European others (one of the parents is of non-
European origin) [20].
j Statistical analysis
General characteristics were compared between case
and control mothers. The continuous variables
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maternal age, time after index-pregnancy and BMI are
presented as medians with 5th and 95th percentiles
and tested using the Mann–Whitney U test because of
skewed distributions. The categorical variables eth-
nicity and educational level and the dichotomous
variables use of alcohol, cigarettes and folic acid
containing (multi) vitamin supplements are presented
as numbers with percentages and tested using the v2
test. The residual method was used to calculate energy
adjusted nutrient intakes [40]. Except for cholesterol,
folate, riboflavin and nicotinamide, the distributions
of all nutrients were positively skewed and therefore
log-transformed. The logarithmic transformed nutri-
ent intakes of the individuals were regressed on their
logarithmic transformed total intake of energy in MJ.
This regression equation was used to calculate the
predicted mean nutrient intake at the average energy
intake of the total study population. By adding the
predicted mean nutrient intake to the individual
residuals, the nutrient intakes were energy adjusted.
Energy adjusted nutrient intakes are presented as
medians with 5th and 95th percentiles and compared
between cases and controls by the Mann–Whitney U
test. Spearman’s correlation coefficients were com-
puted to assess the correlations between the nutrients.
For each nutrient, univariate and multivariate logistic
regression analyses were performed. We created the
25th percentile of dietary nutrient intakes based on
the distribution in control mothers and estimated the
risk for a CHD affected pregnancy by calculating odds
ratios (OR) and their respective 95% confidence
intervals (CI). Furthermore, multivariable logistic
regression analysis with the B-vitamins folate, ribo-
flavin and nicotinamide as continuous variables was
performed to assess the independent relationship of
B-vitamin intake via the diet and CHD risk. To adjust
for potential confounding factors, we fitted a back-
ward stepwise multiple logistic model. The presence
or absence of CHD was the dependent variable.
Covariates were maternal age, diabetes, BMI, ethnic-
ity, educational level, periconception folic acid con-
taining supplement, cigarette or alcohol use. The ORs
were adjusted for maternal age and ethnicity, as only
these predictors remained significant in the logistic
model with P values of <0.05. Because mothers who
used vitamin supplements in the periconception
period had higher total B vitamin intakes than non-
users, we performed a stratified analysis for pericon-
ception use of vitamins, supplements containing folic
acid only, and non-supplement use. Probability values
Table 1 General characteristics of the study population of case and control mothers
Mothers Total CHD group
(n = 276)
Outflow tract
defects (n = 190)
Non-outflow tract
defects (n = 86)
Control group
(n = 324)
16 months after the index-pregnancy
Maternal age (years) 33.1 (25.1–41.6)a 33.2 (24.4–42.3)a 32.9 (25.5–39.0) 32.7 (24.5–39.8)
Time after index-pregnancy (months) 16.2 (13.9–26.6) 16.1 (13.8–27.3) 16.5 (13.8–25.5) 16.1 (14.0–21.9)
BMI (kg/m2) 24.1 (19.2–34.1) 24.3 (19.1–34.2) 23.5 (19.5–32.1) 24.1 (19.6–34.6)
Ethnicityb
Dutch native 221 (80) 146 (77) 25 (87)e 258 (80)
European others 14 (5) 8 (4) 6 (7) 15 (5)
Non-European others 41 (15) 36 (19) 5 (6) 51 (16)
Educational levelc
Low 74 (27) 56 (29) 18 (21) 77 (24)
Intermediate 129 (47) 85 (45) 44 (51) 165 (51)
High 73 (26) 49 (26) 24 (28) 82 (25)
Use of [n (%)]
Alcohol 139 (50) 91 (48)d 48 (56) 185 (57)
Cigarettes 55 (20) 37 (20) 18 (21) 63 (19)
Folic acid (multi)vitamins 55 (20) 32 (17) 23 (27) 67 (21)
Periconception
Use of [n (%)]
Alcohol 94 (34) 62 (33) 32 (37) 107 (33)
Cigarettes 51 (19) 34 (18) 17 (20) 71 (22)
Folic acid (multi)vitamins 135 (49) 93 (49) 42 (49) 163 (50)
Values are given in median (P5–P95) or number (percentage). BMI: n = 2 missing
aP = 0.01, significance tested by the Mann–Whitney U test
bDutch natives: Both parents are from European origin and born in the Netherlands. European others: one of the parents is born in a European country or is from
European origin and living in the USA, Australia or Indonesia. Non-European others: one of the parents is from non-european origin [20]
cLow (primary/lower vocational/intermediate secondary), intermediate (higher secondary/intermediate vocational) or high (higher vocational/university education)
[31]
dP < 0.05, significance tested by V2 test
eP = 0.05, significance tested by V2 test
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£0.05 were considered statistically significant. All
analyses were performed with SPSS for Windows
software (version 15.0; SPSS Inc, Chicago, IL, USA).
Results
Table 1 summarizes the general characteristics in the
total group of case mothers, stratified for OTDs and
non-OTDs, and control mothers. Overall, case moth-
ers were slightly older than controls with a mean
difference of 0.4 years. Mothers of offspring with non-
OTDs were more often from Dutch origin than the
control group (P = 0.05). The median time after the
index-pregnancy was around 16.1 months and com-
parable between case and control mothers. At
16 months after the index-pregnancy and at the
periconception period all lifestyle behaviours were
comparable between the groups.
The food frequency analyses showed that mothers
of a child with a CHD had a significantly higher intake
of saturated fat and a lower intake of nicotinamide
(Table 2). These results are most pronounced in
mothers of a child with an OTD. Furthermore, this
group also showed significantly lower riboflavin in-
take. The median dietary intakes of energy, unsatu-
rated fats, cholesterol and folate were comparable
between the total CHD and stratified groups com-
pared with controls. The dietary intakes of the fats
were positively correlated. Spearman’s correlation
coefficients varied from 0.34 for the intake of cho-
lesterol and saturated fat to 0.53 for the intake of
monounsaturated and saturated fats. B-vitamins were
correlated with Spearman’s correlation coefficients
varying from 0.23 for riboflavin and nicotinamide,
0.29 for folate and nicotinamide, to 0.35 for folate and
riboflavin.
A maternal dietary intake of monounsaturated fats
below the 25th percentile of controls, i.e., 23.1 mg/d,
was associated with a reduced risk of CHD, particu-
larly OTDs (OR 0.6, 95%CI 0.4–0.99) (Table 3). A
dietary intake of cholesterol below the 25th percentile
of intake in controls was associated with a reduced
risk of having a child with a non-OTD (OR 0.5, 95%CI
0.3–0.95). The risk of offspring with OTDs was sig-
nificantly higher with dietary intakes of riboflavin and
nicotinamide below the 25th percentile of intakes in
control mothers (OR 1.7, 95%CI 1.1–2.5 and OR 1.6,
95%CI 1.06–2.5, respectively). A multivariable model
with the three B-vitamins folate, riboflavin and nico-
tinamide was used to determine the independent
associations with CHD risk (Table 4). We demon-
strated a dose-response relationship with increasing
intakes of nicotinamide and decreasing CHD risk (OR
0.8, 95%CI 0.7–1.001, per unit standard deviation
increase). This association was independent of dietary
folate and riboflavin intake.
Stratification for periconception use of vitamins,
supplements containing folic acid only, and non-
supplement use revealed that the association between
a dietary intake of riboflavin below 1.20 mg/d and
OTD risk was strengthened, but only significant in
non-supplement users (OR 2.4, 95%CI 1.4–4.0). A
maternal dietary intake of nicotinamide below the
25th percentile of controls, i.e., 13.5 mg/d, was also
associated with a higher risk of having a child with an
Table 2 Energy adjusted nutrient intakes for case mothers and controls
FCSa Total case group
(n = 276)
Outflow tract defects
(n = 190)
Non-outflow tract defects
(n = 86)
Control group
(n = 324)
Energy (MJ) 8.5 8.7 (5.8–14.0) 8.7 (5.8–13.9) 8.8 (5.7–14.2) 8.8 (5.7–13.2)
Macronutrients
Total fat (g) 85 83.6 (62.8–107.9) 84.0 (62.4–108.0) 82.3 (65.1–107.7) 82.8 (63.1–103.6)
Saturated fat (g) 33 30.7 (21.8–42.3)b 30.9 (21.6–42.4)c 30.3 (22.3–42.5) 29.8 (21.2–40.5)
Monounsaturated fat (g) 30 26.4 (19.2–36.4) 26.4 (18.7–37.4) 26.5 (19.7–33.7) 26.2 (19.3–34.1)
Polyunsaturated fat (g) 15 17.7 (11.2–27.0) 17.9 (11.2–28.1) 16.9 (10.7–26.6) 17.5 (12.0–26.5)
Linoleic acid (g) – 13.6 (8.6–22.4) 13.9 (8.6–22.8) 13.0 (8.3–21.0) 14.0 (9.2–21.9)
ALA (g) – 1.14 (0.66–1.86) 1.13 (0.64–1.87) 1.16 (0.66–1.91) 1.07 (0.74–2.01)
EPA (g) – 0.03 (0.00–0.19) 0.03 (0.00–0.16) 0.04 (0.00–0.25) 0.03 (0.00–0.14)
DHA (g) – 0.06 (0.01–0.29) 0.06 (0.01–0.23) 0.07 (0.01–0.36) 0.07 (0.01–0.21)
Cholesterol (mg) 200 171 (107–267) 177 (102–283) 179 (124–262) 176 (111–281)
Micronutrients
Folate (lg) 153 191 (118–284) 189 (118–276) 195 (119–323) 199 (130–287)
Riboflavin (mg) 1.4 1.34 (0.74–1.08) 1.32 (0.72–2.09)c 1.38 (0.93–2.11) 1.41 (0.86–2.00)
Nicotinamide (mg) – 14.7 (9.90–19.7)c 14.6 (9.6–20.1)c 14.9 (10.7–19.1) 15.1 (10.9–20.1)
Energy-adjusted intakes are medians (P5–P95)
ALA a-linolenic acid, EPA eicosapentanoic acid, DHA docosahexanoic acid
aFood Consumption Survey [22] based on women aged 22–50 years. Significance tested by Mann–Whitney U test
bP = 0.05, significance tested by the Mann–Whitney U test
cP < 0.05, significance tested by the Mann–Whitney U test
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OTD but only in non-supplement users (OR 1.99,
95%CI 1.14–3.46).
Discussion
This study demonstrates that dietary intakes of satu-
rated fat were slightly but significantly higher in
mothers of a child with a CHD than in controls. On
the other hand, dietary intakes of fat-related B-vita-
mins, i.e., riboflavin and nicotinamide, were signifi-
cantly lower in case mothers, in particular mothers of
a child with an OTD, compared with controls. A
dietary intake of riboflavin and nicotinamide below
1.20 and 13.5 mg/d, respectively, more than 2-fold
increased the risk of CHDs, especially in mothers who
did not use vitamin supplements in the periconcep-
tional period. CHD risk decreased with increasing
intakes of nicotinamide, which seemed to be inde-
pendent of dietary folate and riboflavin intake. Med-
ian nutrient intakes were similar to those of the Dutch
National food consumption survey (FCS) [22], indi-
cating that dietary intakes of case and control moth-
ers generally reflect the intakes of Dutch non-
pregnant women aged 22–50 years. Besides this study,
research on the associations between dietary fat,
riboflavin and nicotinamide is lacking and the
underlying mechanisms are unknown. Nevertheless,
our findings are in line with the associations dem-
onstrated between maternal dietary intake of nico-
tinamide and riboflavin and the risk of a child with an
orofacial cleft or spina bifida [11, 19]. CHDs share
similarities in the pathogenesis of spina bifida and
orofacial clefts, because of the involvement of neural
crest cells which are very sensitive to exposures of
folate and homocysteine [1, 4, 28]. Riboflavin and
Table 3 Energy adjusted nutrient intakes and the risk of congenital heart defects
Cut off levels Total group
cases/controls
(n = 276/324)
OR (95%CI) OTDs vs controls
cases/controls
(n = 190/324)
OR (95%CI) Non-OTDs
vs. controls
cases/controls
(n = 86/324)
OR (95%CI)
Macronutrients
Total fat <74.9 g/d 55/81 0.8 (0.5–1.2) 32/81 0.6 (0.4–0.97) 23/81 1.2 (0.7–2.1)
Saturated fat <26.9 g/d 64/81 1.0 (0.7–1.4) 43/81 0.9 (0.6–1.4) 21/81 1.1 (0.6–1.9)
Monounsaturated fat <23.1 g/d 50/81 0.7 (0.4–0.99) 34/81 0.6 (0.4–0.99) 16/81 0.8 (0.4–1.4)
Polyunsaturated fat <15.0 g/d 75/81 1.1 (0.8–1.6) 54/81 1.2 (0.8–1.8) 21/81 1.0 (0.6–1.7)
Linoleic acid <11.9 g/d 77/81 1.2 (0.8–1.7) 52/81 1.1 (0.7–1.7) 25/81 1.2 (0.7–2.1)
ALA <0.89 g/d 53/81 0.7 (0.5–1.1) 37/81 0.8 (0.5–1.2) 16/81 0.7 (0.4–1.2)
EPA <0.01 g/d 68/81 1.1 (0.7–1.6) 49/81 1.2 (0.8–1.9) 19/81 0.9 (0.5–1.5)
DHA <0.03 g/d 74/81 1.2 (0.8–1.8) 54/81 1.1 (0.9–2.1) 20/81 0.9 (0.5–1.6)
Cholesterol <145 mg/d 60/81 0.9 (0.6–1.3) 48/81 1.1 (0.7–1.6) 12/81 0.5 (0.3–0.95)
Micronutrients
Folate <165 lg/d 81/80 1.3 (0.9–1.9) 58/81 1.5 (0.97–2.2) 22/81 1.0 (0.6–1.8)
Riboflavin <1.20 mg/d 89/81 1.6 (1.1–2.3) 65/81 1.7 (1.1–2.5) 24/81 1.3 (0.8–2.3)
Nicotinamide <13.5 mg/d 89/81 1.6 (1.1–2.2) 62/81 1.6 (1.1–2.4) 27/81 1.5 (0.9–2.5)
Cut off values were based on the lowest quartile of intake of the control mothers. The reference category was a dietary intake above the cut off value. ORs were
adjusted for maternal age and ethnicity
OR odds ratio, CI confidence interval, OTD outflow tract defect, ALA a-linolenic acid, EPA eicosapentanoic acid, DHA docosahexanoic acid
Table 4 Multivariable regression analysis of the association between dietary intake of B-vitamins and the risk of congenital heart defects
Total group
cases/controls
(n = 276/324)
P-value
OTDs vs. controls
Cases/controls
(n = 190/324)
P-value
Non-OTDs
vs. controls
cases/controls
(n = 86/324)
P-valueOR (95%CI) OR (95%CI) OR (95%CI)
Modela
Folate 1.0 (0.8–1.2) 0.63 1.1 (1.0–1.1) 0.23 1.1 (0.9–1.5) 0.42
Riboflavin 0.9 (0.8–1.1) 0.32 0.9 (0.7–1.1) 0.25 1.0 (0.7–1.3) 0.98
Nicotinamide 0.8 (0.7–1.001) 0.051 0.8 (0.7–1.02) 0.08 0.8 (0.6–1.1) 0.13
The results of the logistic regression analysis are presented as odds ratio (OR) of CHD risk for one-unit-standard deviation increase in B-vitamins. Folate, 1
SD = 52.3 lg/d. Riboflavin, 1 SD = 0.36 mg/d. Nicotinamide, 1 SD = 3.11 mg/d. ORs were adjusted for maternal age and ethnicity
CI confidence interval, OTD outflow tract defects, Non-OTD non-outflow tract defects
aB-vitamins adjusted for each other
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nicotinamide are coenzymes in fat metabolism and
are important in molecular biological processes cru-
cial for normal embryonic heart development, such as
reduction of lipid peroxides [25, 27], cholesterol and
steroid synthesis, glycolysis, regulation of numerous
oxidoreductases and DNA repair mechanisms [18].
Riboflavin is also a co-factor in the folate pathway,
and might exert its effect via both folate and fat
metabolism.
We have shown a higher CHD risk for low dietary
intakes of riboflavin and nicotinamide, particularly in
mothers who did not use vitamin supplements in the
periconceptional period. Thirty-six case mothers and
thirty-nine controls used also a B-vitamin supple-
ment. The dosage of the B-vitamins in supplements is
much higher than in food. This may explain why we
could not assess a higher CHD risk of low dietary
intake of B-vitamins in this group. Periconception
supplement use was defined as the daily use of vita-
min supplements from four weeks before until eighth
weeks after conception. Some mothers categorized as
non-supplement users were in fact irregular users,
which may have underestimated the OR of low dietary
riboflavin and nicotinamide intake in this group.
Maternal education, as a proxy for socio-economic
status, was lower in mothers who did not use vitamin
supplements in the periconception period. Further-
more, it is known that maternal education is corre-
lated with periconception supplement use [6].
Therefore, the association between B-vitamin intake
and CHD risk may be confounded by education.
Adjustment for education, however, showed that it
only marginally affected the ORs without conse-
quences for the conclusions.
Animal studies have suggested that in utero
exposure to a maternal diet rich in fat may lead to an
increased risk of cardiovascular disease in the off-
spring [16]. Nutrition plays an important role in
epigenetic modification of genes, referring to all
changes in the genes other than the DNA sequence
itself [37]. Mechanisms of epigenetic inheritance in-
clude methylation of DNA, modification of histones,
binding of transcription factors to chromatin, and the
timing of DNA replication. We hypothesize that
inadequate maternal nutrition during the pericon-
ception period, e.g. excess of fatty acids and defi-
ciencies of the B-vitamins riboflavin and nicotinamide
might cause epigenetic changes in the DNA of the
developing embryo resulting in an increased vulner-
ability for an embryo to develop a CHD.
Some strengths and limitations of this study have
to be considered. Because of the relatively low prev-
alence rates of CHDs, we used a case-control study
design with a standardized investigation at 16 months
after the index-pregnancy. We consider this stan-
dardized investigation, of which the value was shown
in our previous studies [11, 19, 34] as one of the main
strengths. The investigation occurred relatively short
after pregnancy to minimize recall bias regarding
periconception lifestyle behaviours and to increase
compliance of the participants. Furthermore, most
CHD are diagnosed during the first year of life and
therefore misclassification of cases and controls is
avoided. Another strength is the detailed character-
isation of CHD phenotypes. To further homogenize
our case group in terms of pathogenesis, we clustered
the OTDs, which have been reported to result from
derangements in folate/homocysteine metabolism [9,
17]. Finally, with regard to nutrition, the study design
considers several measures to reduce bias in nutri-
tional intake. Importantly, we used a validated FFQ
[8], covering the previous four weeks whereby day-to-
day variability of food intake is minimized. Moreover,
the standardized investigation at 16 months after the
index-pregnancy is 2 years after conception and
equals the season of the periconception period. Thus,
the seasonal influences on food intake are comparable
between the groups. Devine et al. [7] support our
approach and state that, in general, no difference
occurs in dietary patterns between the beginning of
pregnancy and at least 1 year postpartum. Further-
more, the famous nutrition epidemiologist Walter
Willet states that dietary patterns are rather stable
[39]. We excluded mothers because of conditions that
affect nutritional intake, such as pregnancy, lactation
or an altered diet compared with the preconception
period. Thirdly, energy adjustment also minimized
possible underreporting bias. The ratio of energy in-
take (EI) and basal metabolic rate (BMR) was com-
parable between cases and controls (OTDs = 1.41;
non-OTDs = 1.43; controls = 1.42). In a separate
analysis, the EI: BMR ratio was 1.41 for Dutch natives,
1.43 for European others and 1.32 for non-Europeans.
The EI: BMI ratio of the total study population was
representative of long-term habitual intake according
to the cut-off value of 1.35 [10]. However, there may
be some underreporting in mothers from non-Euro-
pean origin.
A limitation of our study is the lack of biomarker
data, because B-vitamin concentrations are not only
determined by intake, but also by absorption,
metabolism, clearance and genetic polymorphisms.
Furthermore, we cannot completely rule out the
possibility that the observed associations result from
residual confounding. However, the multiple logistic
regression analysis revealed that maternal diabetes,
BMI, educational level, periconception folic acid
containing supplement use and periconception use of
cigarettes or alcohol did not confound the associa-
tions. Due to the positive correlations among the B-
vitamins, the identification of one B-vitamin with a
predominant role in the pathogenesis of CHD is very
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difficult. Nevertheless, nicotinamide intake seemed to
be associated with CHD risk, independent of dietary
folate and riboflavin. The different B-vitamins are
frequently simultaneously present in foods, making it
difficult to distinguish between the separate effects of
one B-vitamin. Experimental animal studies with
administration of separate B-vitamins could elucidate
this issue further.
Our findings raise questions on the adequacy of the
dietary intake among women of reproductive age,
particularly with regard to riboflavin and nicotin-
amide intakes. Our study population showed ade-
quate dietary intakes of riboflavin and nicotinamide
according to the Dutch recommended dietary allow-
ances [12]. This held even for the majority of mothers
categorized in the lowest quartile of intake based on
the controls. Considering our findings, one may argue
whether the recommendations for riboflavin and
nicotinamide intake are sufficient for women in
reproductive ages and might need to be adapted.
Moreover, acquiring evidence on the safety threshold
for dietary fat intake is a high priority because of the
increasing prevalence of a Western diet rich in fat
even among women of childbearing age. In conclu-
sion, our results suggest that a maternal diet high in
saturated fat but low in riboflavin and nicotinamide
contributes to a higher risk of having a child with a
CHD.
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